This dashboard enables pharmaceutical companies to simulate and manage the impact of international reference pricing (IRP) on margins and revenues. It provides country-specific IRP rules, what-if simulations, launch sequencing analyses, and interactive reports. Companies can predict outcomes of referencing events, price adjustments, or launches, and react quickly to changing conditions. By modeling scenarios and benchmarking launches, users can prevent revenue leakage and optimize strategies. Integrated with PharmaReport, the tool ensures proactive pricing management, improved forecasting, and more resilient financial planning.

Join for free to read